Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Non-Current Receivables Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Omada Health (OMDA) Shares Issued (2024 - 2026)

Omada Health's Shares Issued history spans 2 years, with the latest figure at $156.6 million for Q3 2025.

On a quarterly basis, Shares Issued rose 23417.12% to $156.6 million in Q3 2025 year-over-year; TTM through Dec 2025 was $158.6 million, a N/A change, with the full-year FY2025 number at $160.5 million, up 4722.23% from a year prior.
Shares Issued hit $156.6 million in Q3 2025 for Omada Health, up from $1.3 million in the prior quarter.
Over the last five years, Shares Issued for OMDA hit a ceiling of $156.6 million in Q3 2025 and a floor of $666000.0 in Q3 2024.